Breaking News: The Sankalp Impact HPLC more time and cost effective over CBC

A Deccan Herald article highlighted Sankalp India Foundation’s research on cost-effective screening for thalassemia and sickle cell disease. The study found that using HPLC as the first test detects 14% more carriers early, improving decision-making while keeping costs low. This approach enhances prenatal screening, ensuring timely interventions and better management of blood disorders.